Jenburkt Pharmaceuticals Share Price

    1190.7
    -26.05 (-2.14%)
    JENBURPH • 07 Nov, 2025 | 03:29 PM
    Buy

    1Y Annualised Return

    -0.12%

    3Y Annualised Return

    23.40%

    5Y Annualised Return

    23.75%

    10Y Annualised Return

    9.41%

    The current prices are delayed, login or Open Demat Account for live prices.

    Jenburkt Pharmaceuticals Stock Performance

    1W Return-6.46
    1Y Return-8.76
    Today's Low1170.1
    Prev. Close1,216.75
    Mkt Cap (Cr.)525.49
    1M Return13.45
    3Y Return103.33
    52-Week High1410
    Open1,203.00
    PE Ratio15.92
    6M Return19.58
    Today's High1218
    52-Week Low936.7
    Face Value10

    Jenburkt Pharmaceuticals Company background

    Founded in: 1985
    Managing director: Ashish U Bhuta
    Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.

    Jenburkt Pharmaceuticals Share Price Today


    As of 9 Nov 2025, Jenburkt Pharmaceuticals share price is ₹1190.7. The stock opened at ₹1203 and had closed at ₹1216.8 the previous day. During today’s trading session, Jenburkt Pharmaceuticals share price moved between ₹1,170.10 and ₹1,218.00, with an average price for the day of ₹1194.05. Over the last 52 weeks, the stock has recorded a low of ₹936.70 and a high of ₹1,410.00. In terms of performance, Jenburkt Pharmaceuticals share price has increased by 19.6% over the past six months and has declined by 0.12% over the last year.
    Read More
    Jenburkt Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹3,00,000
    Monthly SIP of 5,000 would have become 5,77,368 in 5 years with a gain of 2,77,368 (+92.46%)
    View details of Market Depth

    Jenburkt Pharmaceuticals Fundamental

    Market Cap (in crs)

    525.49

    Face Value

    10

    Turnover (in lacs)

    19.05

    Key Metrics

    Qtr Change %
    27.12% Gain from 52W Low
    -6.5
    Dividend yield 1yr %
    High in industry
    1.5

    Jenburkt Pharmaceuticals Shareholding Pattern

    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Domestic Institutions
    0.1%
    Public
    53.2%
    Promoter
    46.7%
    Public
    53.3%
    Promoter
    46.7%
    Public
    53.3%

    Jenburkt Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    1190.7
    Current Price
    Bullish Moving Averages
    13
    Bearish Moving Averages
    3
    Day EMA5
    1,210.90
    Day EMA10
    1,182.50
    Day EMA12
    1,172.00
    Day EMA20
    1,144.30
    Day EMA26
    1,134.50
    Day EMA50
    1,131.80
    Day EMA100
    1,146.00
    Day EMA200
    1,134.00
    Day SMA5
    1,243.70
    Day SMA10
    1,174.80
    Day SMA20
    1,114.10
    Day SMA30
    1,100.80
    Day SMA50
    1,106.90
    Day SMA100
    1,194.60
    Day SMA150
    1,166.50
    Day SMA200
    1,138.60
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    1122 Rs
    1600 Rs
    Week Rs
    2156 Rs
    3112 Rs
    Month Rs
    2391 Rs
    3848 Rs
    1,192.93
    Pivot
    Resistance
    First Resistance
    1,215.77
    Second Resistance
    1,240.83
    Third Resistance
    1,263.67
    Support
    First Support
    1,167.87
    Second support
    1,145.03
    Third Support
    1,119.97
    Relative Strength Index
    58.07
    Money Flow Index
    80.15
    MACD
    37.46
    MACD Signal
    19.34
    Average True Range
    55.76
    Average Directional Index
    30.61
    Rate of Change (21)
    13.45
    Rate of Change (125)
    18.64

    Jenburkt Pharmaceuticals Latest News

    29 OCT 2025 | Wednesday

    Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    28 OCT 2025 | Tuesday

    Jenburkt Pharmaceuticals Ltd - 524731 - Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2025.

    28 OCT 2025 | Tuesday

    Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 28Th October, 2025.

    View More

    Jenburkt Pharmaceuticals Share Price FAQs

    You can easily buy Jenburkt Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Jenburkt Pharmaceuticals share price is ₹1410 and ₹936.7 as of 7/11/2025.

    Please be aware that Jenburkt Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Invest in Jenburkt Pharmaceuticals
    +91 -

    Popular Stocks
    318.00
    +0.20 (+0.06%)
    181.37
    +4.10 (+2.31%)
    306.10
    +0.45 (+0.15%)
    414.25
    +5.45 (+1.33%)
    393.20
    +1.45 (+0.37%)
    Top Gainers
    816.35
    +23.85 (+3.01%)
    2,369.40
    +55.10 (+2.38%)
    1,066.60
    +24.70 (+2.37%)
    181.37
    +4.10 (+2.31%)
    3,690.20
    +71.70 (+1.98%)
    Top Losers
    2,001.20
    -93.70 (-4.47%)
    1,167.20
    -23.20 (-1.95%)
    5,583.50
    -109.50 (-1.92%)
    1,386.70
    -26.90 (-1.90%)
    7,642.00
    -140.00 (-1.80%)
    Invest in Jenburkt Pharmaceuticals
    +91 -